Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 2, 2006, Pages 212-217

  Maddalena Ferrari, Maria ^a   Luisa Biondi, Maria ^a   Rossi, Gabriela ^a   Grijuela, Barbara ^a   Gaita, Sara ^a   Perugino, Giuseppe ^a   Viganò, Paola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Endometriosis; Matrix metalloproteinases; Promoter region polymorphisms

Indexed keywords

GELATINASE A; GENOMIC DNA; INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADULT; ALLELE; ARTICLE; BLOOD DONOR; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; GYNECOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; ULTRASOUND; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; GENETICS; MIDDLE AGED;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 33645646758     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340500345287     Document Type: Article

References (28)

1. Viganò P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18:177-200.
2. Nap AW, Groothuis PG, Demir AY, Evers JLH, Dunselman GAJ. Pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2004;18:233-44.
3. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumour invasion. Physiol Rev. 1993;73:161-95.
4. Tamakoshi K, Kikkawa F, Nawa A, Mizuno H. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynaecologic cancer tissues with clinically different metastatic form. Cancer. 1995;76:2565-71.
5. Rosenthal EL, Johnson TM, Allen ED, Apel IJ, Puntunieri A, Weiss SJ. Role of plasminogen activator and matrix metalloproteinase systems in epidermal growth factor and scatter factor stimulated invasion of carcinoma cells. Cancer Res. 1998;58:5221-30.
6. Iurlaro M, Loverro G, Vacca A, Cormio G, Ribatti D, Minischetti M, et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Eur J Clin Invest. 1999;29:793-801.
7. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18:1135-49.
8. Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod. 1997;3:27-4.
9. Sillem M, Prifti S, Neher M, Runnebaum B. Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis. Hum Rep Update. 1998;4:730-5.
10. Goffin F, Munaut C, Frankenne F, Perrier d'Hauterive S, Béliard A, Fridman V, et al. Expression pattern of metalloproteinases and tissue inhibitors of matrix metalloproteinases in cycling human endometrium. Biol Reprod. 2003;69:976-84.
11. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M. Matrix metalloproteinase-9 and tissue inhibitor of Metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril. 2001;75:152-9.
12. Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y, et al. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of matrix metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril. 2002;78:787-95.
13. Osteen KG, Yeaman GR, Bruner Tran KL. Matrix metalloproteinases and endometriosis. Semin Reprod Med. 2003;21:155-64.
14. Mizumoto H, Saito T, Ashihara K, Nishimura M, Takehara M, Tanaka R, et al. Expression of matrix metalloproteinases in ovarian endometriomas: immunohistochemical study and enzyme immunoassay. Life Sci. 2003;71:259-73.
15. Cox KE, Piva M, Sharpe-Timms KL. Differential regulation of metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod. 2001;65:1297-303.
16. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol. 1993;168:253-60.
17. Kokorine I, Nisolle M, Donnez J, Eeckhout Y, Courtoy P, Marbaix E. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril. 1997;68:246-51.
18. Shu Y. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various disease. Matrix Biol. 2000;19:623-9.
19. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998;58:5321-5.
20. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and insertion/deletion polymorphism in its promoter region. Cancer Res. 1999;59:4225-7.
21. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res. 2001;72:2344-6.
22. Szyllo K, Smolarz B, Romanowicz-Makowska H, Niewiadomski M, Kozlowska E, Kulig A. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer. J Exp Clin Cancer Res. 2002;21:357-61.
23. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67: 817-21.
24. Bischoff FZ, Simpson JL. Genetics of endometriosis. Heritability and candidate genes. Best Pract Res Clin Obstet Gynaecol. 2004;18:219-32.
25. Vignali M, Infantino M, Matrone R, Chiodo I, Somigliana E, Busacca M, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril. 2002;78:665-78.
26. Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A. Invasiveness of endometriotic cells in vitro. Lancet. 1995;150:1463-4.
27. Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, et al. A single nucleotide polymorphism in the metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res. 2003;91:612-5.
28. Zondervan KT, Cardon LR, Kennedy S. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod. 2002;17:1415-23.